← back to search

Olivier Rouvière

Université Claude Bernard Lyon 1 · FR
Area of research
Pulmonary and Respiratory Medicine · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Prostate Cancer Diagnosis and Treatment, Prostate Cancer Treatment and Research, MRI in cancer diagnosis, and Advanced Radiotherapy Techniques.
h-index
66
citations
28,147
works
492
NIH funding
primary concept
Medicine
email

Recent publications

AI-Assisted vs Unassisted Identification of Prostate Cancer in Magnetic Resonance Images
JAMA Network Open 2025cited by 22position: middledoi
SPARC: The Standardised Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Analysis and Reporting Consensus: A Delphi Analysis
European Urology 2025cited by 12position: middledoi
Requirements for AI Development and Reporting for MRI Prostate Cancer Detection in Biopsy-Naive Men: PI-RADS Steering Committee, Version 1.0
Radiology 2025cited by 12position: middledoi
Requirements for AI Development and Reporting for MRI Prostate Cancer Detection in Biopsy-Naive Men: PI-RADS Steering Committee, Version 1.0.
2025cited by 7position: contributordoi
Relaxing the PI-RADS dominant sequence rule improves the characterization of high-grade prostate cancer on multiparametric MRI.
2025cited by 1position: contributordoi
Node-RADS: Finally, something new on the front of cross-sectional imaging of lymph nodes?
2025cited by 0position: contributordoi
External Validation on a Japanese Cohort of a Computer-Aided Diagnosis System Aimed at Characterizing ISUP ≥ 2 Prostate Cancers at Multiparametric MRI.
2025cited by 0position: contributordoi
EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer—2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent
European Urology 2024cited by 1,013position: middledoi
EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II—2024 Update: Treatment of Relapsing and Metastatic Prostate Cancer
European Urology 2024cited by 297position: middledoi
Evaluating Biparametric Versus Multiparametric Magnetic Resonance Imaging for Diagnosing Clinically Significant Prostate Cancer: An International, Paired, Noninferiority, Confirmatory Observer Study
European Urology 2024cited by 56position: middledoi
The Transatlantic Recommendations for Prostate Gland Evaluation with Magnetic Resonance Imaging After Focal Therapy (TARGET): A Systematic Review and International Consensus Recommendations
European Urology 2024cited by 37position: middledoi
Clinical practice recommendations for kidney involvement in tuberous sclerosis complex: a consensus statement by the ERKNet Working Group for Autosomal Dominant Structural Kidney Disorders and the ERA Genes & Kidney Working Group
Nature Reviews Nephrology 2024cited by 29position: middledoi
Endometriosis and risk of adverse pregnancy outcomes: a retrospective multicenter cohort study
Fertility and Sterility 2024cited by 13position: middledoi
Multiparametric MRI: can we assess renal function differently?
Clinical Kidney Journal 2024cited by 12position: middledoi
Deep learning-based segmentation of kidneys and renal cysts on T2-weighted MRI from patients with autosomal dominant polycystic kidney disease.
2024cited by 3position: contributordoi
Evaluation of automated prostate segmentation: The complex issue of the optimal number of expert segmentations.
2024cited by 2position: contributordoi
Stereotactic body radiotherapy for inoperable patients with renal carcinoma.
2024cited by 0position: contributordoi
Prostatic artery embolisation versus medical treatment in patients with benign prostatic hyperplasia (PARTEM): a randomised, multicentre, open-label, phase 3, superiority trial
The Lancet Regional Health - Europe 2023cited by 44position: middledoi
Artificial intelligence algorithms aimed at characterizing or detecting prostate cancer on MRI: How accurate are they when tested on independent cohorts? - A systematic review.
2023cited by 28position: contributordoi
Impact of Epithelial Histological Types, Subtypes, and Growth Patterns on Oncological Outcomes for Patients with Nonmetastatic Prostate Cancer Treated with Curative Intent: A Systematic Review
European Urology 2023cited by 26position: middledoi
A Systematic Review of the Efficacy and Toxicity of Brachytherapy Boost Combined with External Beam Radiotherapy for Nonmetastatic Prostate Cancer
European Urology Oncology 2023cited by 20position: middledoi
Impact of Epithelial Histological Types, Subtypes, and Growth Patterns on Oncological Outcomes for Patients with Nonmetastatic Prostate Cancer Treated with Curative Intent: A Systematic Review.
2023cited by 18position: contributordoi
French recommendations for the diagnosis and management of lymphangioleiomyomatosis
Respiratory Medicine and Research 2023cited by 17position: middledoi
Characterization of high-grade prostate cancer at multiparametric MRI: assessment of PI-RADS version 2.1 and version 2 descriptors across 21 readers with varying experience (MULTI study)
Insights into Imaging 2023cited by 16position: middledoi
Safety and Efficacy of Stereotactic Ablative Radiation Therapy for Renal Cell Cancer: 24-Month Results of the RSR1 Phase 1 Dose Escalation Study.
2023cited by 15position: contributordoi
A multicenter comparative matched-pair analysis of percutaneous tumor ablation and robotic-assisted partial nephrectomy of T1b renal cell carcinoma (AblatT1b study-UroCCR 80).
2023cited by 15position: contributordoi
Characterization of high-grade prostate cancer at multiparametric MRI using a radiomic-based computer-aided diagnosis system as standalone and second reader
Diagnostic and Interventional Imaging 2023cited by 13position: contributordoi
Characterization of high-grade prostate cancer at multiparametric MRI: assessment of PI-RADS version 2.1 and version 2 descriptors across 21 readers with varying experience (MULTI study).
2023cited by 9position: contributordoi
Systematic Biopsies as a Complement to Magnetic Resonance Imaging-targeted Biopsies: "To Be or Not To Be"?
2023cited by 8position: contributordoi
French recommendations for the diagnosis and management of lymphangioleiomyomatosis.
2023cited by 7position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

Ann Henry · University of Leeds24 papers (2016–2023) · 22 papers (2019–2025)Silke Gillessen · University Hospitals Seidman Cancer Center17 papers (2019–2023)Nicolas Mottet · Total (France)15 papers (2015–2022)Sébastien Crouzet · Université Claude Bernard Lyon 114 papers (2013–2023)Ivo G. Schoots · Erasmus MC13 papers (2016–2025)Marc Colombel · Hôpital Lyon Sud12 papers (2012–2023)Flavie Bratan · Université Claude Bernard Lyon 112 papers (2012–2018)Florence Mège‐Lechevallier · Université Claude Bernard Lyon 111 papers (2012–2018)Henk G. van der Poel · Amsterdam UMC Location Vrije Universiteit Amsterdam11 papers (2015–2021)Thomas Lam · Sun Yat-sen University Cancer Center11 papers (2015–2021) · 11 papers (2015–2021)Rémi Souchon · Université Claude Bernard Lyon 110 papers (2013–2023)Maria De Santis · Humanitas University10 papers (2016–2021)Valeria Panebianco · Université Claude Bernard Lyon 110 papers (2019–2025)Jelle O. Barentsz · AkzoNobel (Netherlands)9 papers (2012–2024)Malcolm D. Mason · Cardiff University9 papers (2015–2021) · 9 papers (2015–2021)Thomas Wiegel · Universität Ulm9 papers (2015–2021)Thomas Van den Broeck · KU Leuven8 papers (2015–2021)